Vaccine safety data Safety data Main navigation COVID-19 vaccines Influenza vaccines Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Vaccine safety in Australia AusVaxSafety summary reports AusVaxSafety is an active vaccine safety surveillance system that monitors the safety of vaccines in Australia. Using de-identified data reported directly from people receiving the vaccines (or their parent or carer), AusVaxSafety monitors adverse events following immunisation and facilitates early detection of potential vaccine safety issues. More information on AusVaxSafety active vaccine safety surveillance here. COVID-19 vaccines AusVaxSafety is conducting active surveillance of COVID-19 vaccine safety. Click here to access the latest data. Influenza vaccines AusVaxSafety is undertaking active surveillance of influenza vaccine safety. Click here to access the latest data. Mpox (monkeypox) vaccine AusVaxSafety is conducting active surveillance of mpox vaccine safety. Click here to access the latest data. National Immunisation Program schedule vaccines AusVaxSafety is undertaking active surveillance of NIP vaccine safety. Click here to access the latest data. Nirsevimab AusVaxSafety is undertaking enhanced surveillance of nirsevimab in Australia. Click here to access the latest data. RSV vaccines AusVaxSafety is undertaking enhanced surveillance of RSV vaccines in use in Australia. Click here to access the latest data. Vaccine safety in Australia AusVaxSafety summary reports The reports shows how parents and carers responded to a vaccine safety survey following immunisation Safety data Main navigation COVID-19 vaccines Influenza vaccines Mpox (monkeypox) vaccine National Immunisation Program schedule vaccines Nirsevimab RSV vaccines Vaccine safety in Australia AusVaxSafety summary reports News & events All news & events 21 May 2026 | News Australia’s first real-world safety data confirm nasal spray influenza vaccine is well-tolerated by children and adolescents 02 April 2026 | News AusVaxSafety begins surveillance of 2026 influenza vaccines, including new nasal spray option 05 March 2026 | News New LP.8.1 COVID-19 vaccines well tolerated, new AusVaxSafety data show 14 July 2025 | News Fewer adverse events reported following NIP pneumococcal vaccine change